Home / Healthcare / Respiratory Devices Market

Respiratory Devices Market Size, Share & Industry Analysis, By Product (Therapeutic Devices, Monitoring Devices), By Indication (Asthma, Chronic Bronchitis, Chronic Obstructive Pulmonary Disease (COPD), Pleural Effusion, Others) and Regional Forecast, 2024-2032

Report Format: PDF | Published Date: Ongoing | Report ID: FBI101424 | Status : Upcoming

Respiratory devices are used to provide respiratory gases to the patients suffering from respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, pneumonia, and pulmonary disease. Growing prevalence of the respiratory diseases, changing lifestyles, and increase in the level of pollutions are some of the significant factors likely to enhance the demand for the effective respiratory devices for the diagnostic and monitoring of the respiratory diseases.


According to the report published in 2017, by the World Health Organization (WHO), it was estimated that around 65 million people had moderate to severe chronic obstructive pulmonary disease (COPD) and more than 100 million people suffered from sleep-breathing disorders. Growing investments by many key players and rising awareness about the innovative devices for diagnostic and treatment of respiratory diseases are likely to fuel the respiratory devices market growth during the forecast period.



Growing technological advancements in respiratory devices, ease of use of respiratory devices, and growing prevalence of various respiratory diseases across the globe are likely to boost the demand for respiratory devices market growth during the forecast period. Also, growing investments in R&D activities by many key players and government organizations are likely to drive for innovative respiratory devices market growth during the forecast period.


However, lack of awareness about innovative respiratory devices in emerging nations is likely to hinder the respiratory devices market growth during the forecast period.


Key Players Covered


Some of the major companies that are present in the global respiratory devices market report include Invacare Corporation., Medtronic, GlaxoSmithKline plc., Chart Industries, General Electric Company, ResMed. and others.


Segmentation






















 ATTRIBUTE


 DETAILS

By Product




  • Therapeutic Devices



  • Drug Delivery Devices

  • Mechanical Ventilators

  • Continuous Positive Airway Pressure

  • Resuscitators

  • Humidifiers

  • Airway Clearance Devices

  • Oxygen Concentrators

  • Consumables & Disposables

  • Others



  • Monitoring Devices



  • Pulse Oximeters

  • Capnographs

  • Spirometers

  • Polysomnographs

  • Peak Flow Meters

  • Gas Analyzers

  • Others



By Indication




  • Asthma

  • Chronic Bronchitis

  • Chronic Obstructive Pulmonary Disease (COPD)

  • Pleural Effusion

  • Others



By Geography




  • North America (the USA and Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico and Rest of Latin America)

  • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)



In terms of product segment, monitoring devices segment is anticipated to hold the largest respiratory devices market share during the forecast period they aid in real time monitoring of the respiratory rate in addition to the growing demand of technologically advanced monitoring devices.


Key Insights



  • Overview of Newly Approved Respiratory Devices

  • The Regulatory Scenario for Key Countries/Regions

  • Overview of The Prevalence of Respiratory Disease Globally-2018

  • Key Industry Development Partnerships, Mergers, and Acquisitions-2018


Regional Analysis


Geographically, the global respiratory devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to dominate the global respiratory devices market during the projected period owing to the growing prevalence of respiratory disease and increase in the adoption of various respiratory device used for the treatment of chronic respiratory disease treatment procedure. In Europe, growing investments by government organizations in research and development activities and growing collaborations among many key players to develop cost-effective as well as portable devices are likely to boost the respiratory devices market growth during the forecast period. Asia Pacific is anticipated to register significant CAGR in respiratory devices market owing to the growing patient population and rising awareness about various respiratory disease and its treatment options available.


Key Industry Developments



  • In February 2019, VAPOTHERM launched its next-gen Precision Flow Hi-VNI system intended to relieve respiratory stress in spontaneously breathing patients.

  • In October 2018, AptarGroup, Inc. launched Pure Hale, a New Portable and Ready-to-Use Upper Respiratory Delivery Solution

  • In May 2017, the Drägerwerk AG & CO. KGAA introduced Oxylog VE300, a newly developed emergency and transport ventilator that is particularly apt for use outside of the hospital

  • Global
  • 2023
  • 2019-2022
  • PRICE
  • $ 4850
    $ 5850
    $ 6850
    Pre Book

Healthcare Clients